| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Head and Neck Tumor Biology Program, Departments of Microbiology/Immunology [K. D. S., M. A. M., L. S. I.] and OtolaryngologyHead and Neck Surgery [K. D. S., M. A. M., G. L. S.], Eastern Virginia Medical School, Norfolk, Virginia 23501, and Department of Pediatrics, School of Medicine, University of California at Irvine, Irvine, California 92717 [M. E. L., G. G.]
Squamous cell carcinomas of the head and neck (SCCHN) are associated strongly with the use of tobacco and alcohol, but little is known about the molecular pathogenesis of these tumors. In the present study, we analyzed SCCHN for mutations in the tumor suppressor gene p53 by immunocytochemistry and complementary DNA sequencing. Overexpression of p53 protein was detected in 13 (100%) of 13 SCCHN cell lines and in tumor cells cultured directly from 10 (77%) of 13 patients with SCCHN. Direct evidence for p53 mutations was obtained by sequencing p53 complementary DNA from eight SCCHN cell lines and two tumor xenografts. The genetic alterations included seven missense mutations resulting in single amino acid substitutions, a mutation encoding a stop codon, one 10-base pair deletion, and one 2-base pair addition. All seven missense mutations were G to T transversions, five of which were clustered at codons 245 and 248. A similar high frequency of G to T transversions predominates in lung cancer, another tobacco-related disease. Mutation of the p53 gene is the most common genetic alteration detected in SCCHN and implicates this gene locus as a critical site of specific damage by mutagenic carcinogens in tobacco, one of the important risk factors in the etiology of this disease.
1 Supported by the Medical College of Hampton Roads Foundation.
2 To whom requests for reprints should be addressed.
3 Supported by Grant 1RT343 from the Oxnard Foundation, and the Tobacco-Related Disease Research Program (TRDRP).
Received 4/22/92. Accepted 8/25/92.
This article has been cited by other articles:
![]() |
S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy J. Dent. Res., January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Mitra, S Banerjee, C Misra, R K Singh, A Roy, A Sengupta, C K Panda, and S Roychoudhury Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population J. Clin. Pathol., September 1, 2007; 60(9): 1040 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Chung, J. S. Parker, K. Ely, J. Carter, Y. Yi, B. A. Murphy, K. K. Ang, A. K. El-Naggar, A. M. Zanation, A. J. Cmelak, et al. Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-{kappa}B Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma Cancer Res., August 15, 2006; 66(16): 8210 - 8218. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tokumaru, K. Yamashita, M. Osada, S. Nomoto, D.-I. Sun, Y. Xiao, M. O. Hoque, W. H. Westra, J. A. Califano, and D. Sidransky Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing Cancer Res., September 1, 2004; 64(17): 5982 - 5987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ginos, G. P. Page, B. S. Michalowicz, K. J. Patel, S. E. Volker, S. E. Pambuccian, F. G. Ondrey, G. L. Adams, and P. M. Gaffney Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck Cancer Res., January 1, 2004; 64(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Freie, X. Li, S. L. M. Ciccone, K. Nawa, S. Cooper, C. Vogelweid, L. Schantz, L. S. Haneline, A. Orazi, H. E. Broxmeyer, et al. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis Blood, December 1, 2003; 102(12): 4146 - 4152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Banerjee, V. K. Gopalakrishnan, I. Bhattacharya, and J. K. Vishwanatha Deregulated Cyclooxygenase-2 Expression in Oral Premalignant Tissues Mol. Cancer Ther., December 1, 2002; 1(14): 1265 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Geisler, A. F. Olshan, M. C. Weissler, J. Cai, W. K. Funkhouser, J. Smith, and K. Vick p16 and p53 Protein Expression as Prognostic Indicators of Survival and Disease Recurrence from Head and Neck Cancer Clin. Cancer Res., November 1, 2002; 8(11): 3445 - 3453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and Neck Cancer N. Engl. J. Med., December 27, 2001; 345(26): 1890 - 1900. [Full Text] [PDF] |
||||
![]() |
S. Shintani, M. Mihara, N. Terakado, Y. Nakahara, T. Matsumura, Y. Kohno, H. Ohyama, J. McBride, R. Kent, R. Todd, et al. Reduction of p12DOC-1 Expression Is a Negative Prognostic Indicator in Patients with Surgically Resected Oral Squamous Cell Carcinoma Clin. Cancer Res., September 1, 2001; 7(9): 2776 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Schantz, Q. Huang, K. Shah, V.V.V.S. Murty, T.C. Hsu, G. Yu, P. E. Andersen, A. G. Huvos, and R. S.K. Chaganti Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers Carcinogenesis, June 1, 2000; 21(6): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cabelguenne, H. Blons, I. de Waziers, F. Carnot, A.-M. Houllier, T. Soussi, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series J. Clin. Oncol., April 7, 2000; 18(7): 1465 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Franklin, T. Pho, F. W. Abreo, R. Nassar, A. De Benedetti, F. J. Stucker, and C.-A. O. Nathan Detection of the Proto-oncogene eIF4E in Larynx and Hypopharynx Cancers Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |